DarioHealth (NASDAQ: DRIO), a pioneer in the global digital therapeutics market, has finalized a contract with PeopleOne Health to be the digital behavioral health solution of choice for patients effective in September 2021. PeopleOne Health is a regional care provider, and Dario’s partnership with the company marks the company’s continued expansion and growth in the provider market as it leverages its compelling proprietary product portfolio. The contract outlines PeopleOne Health’s intention to integrate Dario’s digital behavioral health solution to address a wide range of mental health needs for its patients, including support for high-value, holistic care to its growing base of direct consumer and employer partner populations. Dario offers exclusive solutions that utilize AI-driven screening to evaluate individuals and suggest the most appropriate care; Dario’s services also include integrated digital tools and coaching, which provide patients with a clear path from primary care to proven mental health support. “In order to stay competitive, providers require modern solutions that effectively manage the whole health of a patient, and we believe that Dario’s rapid growth reflects strong alignment with market needs across our suite of solutions,” said DarioHealth president and general manager of North America Rick Anderson in the press release. “The agreement with PeopleOne Health represents new proof of value for our digital behavioral health solution as an intervention in point-of-care settings where most mental health needs are diagnosed today.”
To view the full press release, visit https://ibn.fm/EEx92
About DarioHealth Corp.
DarioHealth is a leading global digital therapeutics company revolutionizing how people with chronic conditions manage their health. DarioHealth offers one of the most comprehensive digital therapeutics solutions on the market, covering multiple chronic conditions including diabetes, hypertension, weight management, musculoskeletal and behavioral health within one integrated technology platform. Dario’s next-generation, AI-powered, digital therapeutic platform supports more than just an individual’s disease. Dario provides adaptive, personalized experiences that drive behavior change through evidence-based interventions; intuitive, clinically proven digital tools; high-quality software; and coaching to help individuals improve health and sustain meaningful outcomes. Dario’s unique user-centric approach to product design and engagement creates an unparalleled experience that is highly rated by users and delivers sustainable results. The company’s cross-functional team operates at the intersection of life sciences, behavioral science and software technology, utilizing a performance-based approach to improve users’ health. On the path to better health, Dario makes the right thing to do the easy thing to do. For more information about the company, please visit www.DarioHealth.com.
NOTE TO INVESTORS: The latest news and updates relating to DRIO are available in the company’s newsroom at http://ibn.fm/DRIO
About InvestorWire
InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent. We offer UNLIMITED Words on all domestic releases. While other wire services may provide a basic review of your release, InvestorWire helps you put your best foot forward with complimentary Press Release Enhancement.
With our competitors, the work is done the second your release crosses the wire. Not with InvestorWire. We include follow-up coverage of every release by leveraging the ever-expanding audiences of the 50+ brands that make up the InvestorBrandNetwork.
Get more out of your next press release with InvestorWire. It’s unlike anything you’ve seen before.
For more information, please visit https://www.InvestorWire.com
Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer
InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.InvestorWire.com
[email protected]
InvestorWire is part of the InvestorBrandNetwork.